Work

G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML).

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.2068.2068

Authors: Pamela S. Becker, Elihu Estey, Stephen Petersdorf, Barry E Storer, Frederick R Appelbaum

Institutions: University of Washington, Seattle Cancer Care Alliance, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979831318

FWCI: 1.534

Cites:

Cited by: 7

Related to: 10